Integrichain Blog

Blog

Market Access Blogs Jen Sharpe Jyoti Dubey Jui Andhare
June 28, 2024

States Influence Drug Pricing and Access, Specialty Pharmacies Evolve to Accommodate...

4 Minute Read

Read the latest on how states influence drug pricing and access, specialty pharmacies evolution to supoprt cell & gene therapies, and Walgreens entering the CGT arena.

IRA’s Impact on Medicare Part D Expenditures

Contracts & Pricing Jeff Baab
June 12, 2024

The Wild Ride of Medicare Part D Payer Challenges on Expenditures...

3 Minute Read

Learn about the IRA's changes to Part D benefits have created uncertainty for both manufacturers and payers.

Market Access Blogs Nick Iaconi Carter Hall Jui Andhare
May 30, 2024

IRA Part D Redesign, New Gene Therapies Give Hope for Patients,...

5 Minute Read

Discover the latest on IRA Part D Redesign Financial Implications, New Gene Therapies Give Newfound Hope for Patients, and Impact of Credit Card Fees in Government Pricing.

April Pharmaceutical Industry Market Update

Contracts & Pricing Sarah Vo Brian Bumpus Rupal Patel
April 24, 2024

Changing Pharmacy Reimbursements with CVS, FSS/IFF Reporting Alert & the Latest...

3 Minute Read

Discover the latest on the Pharmacy Reimbursements for CVS, FSS/IFF Reporting Alert, and the 340B Drug Discount Program.

Maze_

Market Access Michael Kerman
April 18, 2024

10 Market Access Issues & Their Warning Signs

5 Minute Read

Navigate market access issues with insights on 10 common warning signs, including outdated legacy mindsets, inadequate data sources, and operational silos.

Illinois Pharma Price Gouging Law Challenged

Contracts & Pricing Jui Andhare Jordan Boruff Olivia Nweze
March 21, 2024

FDA Approves Florida Drug Imports from Canada, GLP-1 Market Dilemma, &...

5 Minute Read

Discover the latest on the FDA Approving Florida's Plan to Import Prescription Drugs from Canada, The GLP-1 Market Dilemma, and Illinois Price Gouging Law updates this month.

Gross to Net Revenue Pharma

Gross-to-Net Jen Sharpe
February 20, 2024

Navigating the Complexities of Biopharma/Pharma Net Revenue Forecasting

3 Minute Read

The gross-to-net process, essential for understanding net revenue, demands a keen awareness of every piece of data and business drivers upstream. In this blog, we'll explore the critical considerations...

Medicare Part D Agreement & WAC Drug Pricing Changes

Contracts & Pricing Ben Fanelli Nick Iaconi Jeff Baab Olivia Nweze
January 31, 2024

The New Medicare Part D Agreement, AMP Removals Impact on WAC...

9 Minute Read

Discover the latest on the New Medicare Part D Agreement, 2024 Pharma Industry Shake-Up andth 2023 SPTR Recap updates this month.

340b contract pharmacy

Channel Dave Weiss
January 25, 2024

Transforming Pharmaceutical Trade and Embracing Innovation in Distribution Paradigms

3 Minute Read

Learn about this transformative period which poses both challenges and opportunities, urging stakeholders to adapt and innovate.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article